Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Thomas A Hope
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
Withdrawn - Tower Cancer Research Foundation
Beverly Hills, California, United States
Andrew E. HendifarRecruiting - Loma Linda University Medical Center
Loma Linda, California, United States
Suspended - Cedars-Sinai Medical Center
Los Angeles, California, United States
Andrew E. HendifarRecruiting - Ucsf Medical Center-Mission Bay
San Francisco, California, United States
Claire MulveyRecruiting - Torrance Memorial Physician Network - Cancer Care
Torrance, California, United States
Andrew E. HendifarRecruiting - Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
Chul KimRecruiting - Um Sylvester Comprehensive Cancer Center at Aventura
Aventura, Florida, United States
Suspended - Um Sylvester Comprehensive Cancer Center at Coral Gables
Coral Gables, Florida, United States
Lawrence M. NegretRecruiting - Um Sylvester Comprehensive Cancer Center at Deerfield Beach
Deerfield Beach, Florida, United States
Lawrence M. NegretRecruiting - University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
Lawrence M. NegretRecruiting - Um Sylvester Comprehensive Cancer Center at Plantation
Plantation, Florida, United States
Lawrence M. NegretRecruiting - University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
Christine M. BestvinaRecruiting - Uc Comprehensive Cancer Center at Silver Cross
New Lenox, Illinois, United States
Christine M. BestvinaRecruiting - University of Chicago Medicine-Orland Park
Orland Park, Illinois, United States
Christine M. BestvinaRecruiting - Ui Health Care Mission Cancer and Blood - Ankeny Clinic
Ankeny, Iowa, United States
Seema Harichand-HerdtRecruiting - Iowa Methodist Medical Center
Des Moines, Iowa, United States
Seema Harichand-HerdtRecruiting - Ui Health Care Mission Cancer and Blood - Des Moines Clinic
Des Moines, Iowa, United States
Seema Harichand-HerdtRecruiting - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Jennifer A. ChanRecruiting - Mayo Clinic in Rochester
Rochester, Minnesota, United States
Thorvardur R. HalfdanarsonRecruiting - Missouri Baptist Medical Center
St Louis, Missouri, United States
Bryan A. FallerRecruiting - Duke University Medical Center
Durham, North Carolina, United States
Michael A. MorseRecruiting - Case Western Reserve University
Cleveland, Ohio, United States
Amr MohamedRecruiting - Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Suspended - Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Sukhmani K. PaddaRecruiting - Temple University Hospital
Philadelphia, Pennsylvania, United States
Sukhmani K. PaddaRecruiting - University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
Suspended - Vanderbilt University/ingram Cancer Center
Nashville, Tennessee, United States
Robert A. RamirezRecruiting - Huntsman Cancer Institute/university of Utah
Salt Lake City, Utah, United States
Heloisa P. SoaresRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Feb 2023
- Primary completion
- 1 Jul 2027
- Completion
- 1 Jul 2027
- Last update posted
- 9 Jul 2026
- Registered enrollment
- 70
- Registry id
- NCT04665739
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.